SPONSOR
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Total Trials
3
Recruiting
3
Phases
N/A
Conditions studied: RadiomicRadiomicsBreast Cancer MetastaticBreast Cancer Stage IVBreast CarcinomaBreast NeoplasmsBreast CancerBreast Cancer With Bone MetastasisBreast Cancer With Metastatic Bone DiseaseTrastuzumab
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Radiomic, Radiomics, Breast Cancer Metastatic, Breast Cancer Stage IV.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
How many clinical trials has Fondazione IRCCS Istituto Nazionale dei Tumori, Milano sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, of which 3 are actively recruiting participants. These trials cover conditions including Radiomic, Radiomics, Breast Cancer Metastatic. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Fondazione IRCCS Istituto Nazionale dei Tumori, Milano research focus on?
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano clinical trials span Radiomic, Radiomics, Breast Cancer Metastatic, Breast Cancer Stage IV, Breast Carcinoma, and additional conditions. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Fondazione IRCCS Istituto Nazionale dei Tumori, Milano clinical trial?
To participate in a Fondazione IRCCS Istituto Nazionale dei Tumori, Milano trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Fondazione IRCCS Istituto Nazionale dei Tumori, Milano trials with current recruitment status updated daily.
Clinical Trials by Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
NCT07030569
Recruiting
RADIomics to Predict HER2 Status And T-DXd Efficacy in Metastatic Breast Cancer: the RADIOSPHER2 Study
Radiomic
NCT06408441
Recruiting
The Epithelioid Hemangioendothelioma Registry of the European Reference Network on Rare Adult Solid Cancers (EURACAN)
Epithelioid Hemangioendothelioma
NCT05550961
Recruiting
APOLLO 11, Consortium of Italian Centers Involved in Treatment of Patients With Lung Cancer Treated With Innovative Therapies: Real World Data and Translational Reaserch
NSCLC
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology